Cargando…

Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial

BACKGROUND: HPV vaccination is recommended in France for all adolescents aged 11-14. Coverage has increased over recent years but remains below 50% by age 15, with social disparities by area deprivation level, parental education and income. We analysed the effect of school-wide campaigns on adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Dussault, J, Le Duc-Banaszuk, A S, Gagneux-Brunon, A, Bruel, S, Gauchet, A, Barret, A S, Sicsic, J, Thilly, N, Mueller, J E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595599/
http://dx.doi.org/10.1093/eurpub/ckad160.398
_version_ 1785124906075160576
author Dussault, J
Le Duc-Banaszuk, A S
Gagneux-Brunon, A
Bruel, S
Gauchet, A
Barret, A S
Sicsic, J
Thilly, N
Mueller, J E
author_facet Dussault, J
Le Duc-Banaszuk, A S
Gagneux-Brunon, A
Bruel, S
Gauchet, A
Barret, A S
Sicsic, J
Thilly, N
Mueller, J E
author_sort Dussault, J
collection PubMed
description BACKGROUND: HPV vaccination is recommended in France for all adolescents aged 11-14. Coverage has increased over recent years but remains below 50% by age 15, with social disparities by area deprivation level, parental education and income. We analysed the effect of school-wide campaigns on adolescent vaccine uptake and related disparities. METHODS: PrevHPV is a controlled cluster-randomised trial to assess the effectiveness and efficiency of a multi-component intervention targeting middle schools and general practitioners. Sixty-one French middle schools were randomised in a partial factorial design to one of six intervention arms, some of which included school-based vaccine campaigns combined with in-class education and motivation. We assessed HPV vaccine status using online questionnaires that were administered in class to pupils (aged 13-15 years) at baseline and after 5 months. Using linear regression, we explored the decomposed effect of campaigns on vaccine uptake and interactions of the effect with sociodemographic variables. RESULTS: In total, 2639 adolescents provided complete vaccination data on both questionnaires, with a ≥ 1-dose coverage of 24% at baseline. Among previously unvaccinated pupils (N = 2017), 21% (7%) of girls (boys) in the control group reported receipt of first vaccine dose during the follow-up period, compared to 49% (33%) in arms with vaccine campaigns. Adjusting for baseline vaccine intention, vaccine campaigns increased the 5-month probability of a first dose by 25 (95% confidence interval: 19-31) percentage points compared to the control group. The effect of vaccine campaigns on student-reported vaccine uptake did not substantially vary by school area deprivation level, parental education level, or family multilingualism (compared to French monolingual family). CONCLUSIONS: School-based campaigns substantially increased vaccine coverage among all adolescents within a short time period. Yet, underlying disparities in HPV vaccination were unchanged. KEY MESSAGES: • School-based vaccine campaigns can quickly increase HPV vaccine uptake among adolescents. • Vaccination campaigns need tailored implementation strategies to eventually reduce social disparities in HPV vaccination.
format Online
Article
Text
id pubmed-10595599
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105955992023-10-25 Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial Dussault, J Le Duc-Banaszuk, A S Gagneux-Brunon, A Bruel, S Gauchet, A Barret, A S Sicsic, J Thilly, N Mueller, J E Eur J Public Health Parallel Programme BACKGROUND: HPV vaccination is recommended in France for all adolescents aged 11-14. Coverage has increased over recent years but remains below 50% by age 15, with social disparities by area deprivation level, parental education and income. We analysed the effect of school-wide campaigns on adolescent vaccine uptake and related disparities. METHODS: PrevHPV is a controlled cluster-randomised trial to assess the effectiveness and efficiency of a multi-component intervention targeting middle schools and general practitioners. Sixty-one French middle schools were randomised in a partial factorial design to one of six intervention arms, some of which included school-based vaccine campaigns combined with in-class education and motivation. We assessed HPV vaccine status using online questionnaires that were administered in class to pupils (aged 13-15 years) at baseline and after 5 months. Using linear regression, we explored the decomposed effect of campaigns on vaccine uptake and interactions of the effect with sociodemographic variables. RESULTS: In total, 2639 adolescents provided complete vaccination data on both questionnaires, with a ≥ 1-dose coverage of 24% at baseline. Among previously unvaccinated pupils (N = 2017), 21% (7%) of girls (boys) in the control group reported receipt of first vaccine dose during the follow-up period, compared to 49% (33%) in arms with vaccine campaigns. Adjusting for baseline vaccine intention, vaccine campaigns increased the 5-month probability of a first dose by 25 (95% confidence interval: 19-31) percentage points compared to the control group. The effect of vaccine campaigns on student-reported vaccine uptake did not substantially vary by school area deprivation level, parental education level, or family multilingualism (compared to French monolingual family). CONCLUSIONS: School-based campaigns substantially increased vaccine coverage among all adolescents within a short time period. Yet, underlying disparities in HPV vaccination were unchanged. KEY MESSAGES: • School-based vaccine campaigns can quickly increase HPV vaccine uptake among adolescents. • Vaccination campaigns need tailored implementation strategies to eventually reduce social disparities in HPV vaccination. Oxford University Press 2023-10-24 /pmc/articles/PMC10595599/ http://dx.doi.org/10.1093/eurpub/ckad160.398 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Dussault, J
Le Duc-Banaszuk, A S
Gagneux-Brunon, A
Bruel, S
Gauchet, A
Barret, A S
Sicsic, J
Thilly, N
Mueller, J E
Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title_full Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title_fullStr Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title_full_unstemmed Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title_short Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
title_sort effect of school-based hpv vaccine campaigns on inequalities in uptake in france: the prevhpv trial
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595599/
http://dx.doi.org/10.1093/eurpub/ckad160.398
work_keys_str_mv AT dussaultj effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT leducbanaszukas effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT gagneuxbrunona effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT bruels effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT gaucheta effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT barretas effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT sicsicj effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT thillyn effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT muellerje effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial
AT effectofschoolbasedhpvvaccinecampaignsoninequalitiesinuptakeinfrancetheprevhpvtrial